Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
US Army
Citi
Chubb
Johnson and Johnson
Julphar
Cerilliant
UBS
Cipla

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017971

« Back to Dashboard

NDA 017971 describes ESKALITH, which is a drug marketed by Noven Therap and Jds Pharms and is included in three NDAs. Additional details are available on the ESKALITH profile page.

The generic ingredient in ESKALITH is lithium carbonate. There are fifteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 017971
Tradename:ESKALITH
Applicant:Jds Pharms
Ingredient:lithium carbonate
Patents:0
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017971

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
Boehringer Ingelheim
Harvard Business School
US Department of Justice
Covington
Julphar
Chubb
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.